Regulation of pre-mRNA splicing in metazoa

Current Opinion in Genetics and Development

Volumn 7, Issue 2, 1997, Pages 205-211

  Wang, Jin ^a   Manley, James L ^a  

^a Sherman Fairchild Ctr for Life Sci ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PHOSPHOTRANSFERASE; PROTEIN; TRANS ACTING FACTOR;

ARTICLE; CELL VIABILITY; DROSOPHILA; HUMAN; METAZOON; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RNA SEQUENCE; RNA SPLICING;

EID: 0031009398     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(97)80130-X     Document Type: Article

References (53)

1. Moore MJ, Query CC, Sharp PA: Splicing of precursors to messenger RNAs by the spliceosome. In The RNA World. Edited by Gesteland RF, Atkins JF. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 193:303-358.
2. Fu XD: The superfamily of arginine/senne-rich splicing factors. RNA 1995, 1:663-630.
3. Manley JL, Tacke R: SR proteins and splicing control. Genes Dev 1996, 10:1569-1579.
4. Madhani HD, Guthrie C: Dynamic RNA-RNA interactions in the spliceosome. Annu Rev Genet 1994, 28:126.
5. Adams MD, Runder DZ, Rio DC: Biochemistry and regulation of pre-mRNA splicing. Curr Opin Cell Biol 1996, 8:331-339.
6. Crispino JD, Blencowe BJ. Sharp PA: Complementation by SR proteins of pre-mRNA splicing reactions depleted of U1 snRNP. Science 1994, 265:1866-1869.
7. Tarn WY, Steitz JA: SR proteins can compensate for the loss of U1 snRNP functions in vitro. Genes Dev 1994, 8:2704-2717.
8. Tarn WY, Steitz JA: Modulation of 5′ splice site choice in premessenger RNA by two distinct steps. Proc Natl Acad Sci USA 1995, 92:2504-2508.
9. Crispino JD, Sharp PA: A U6 snRNA: pre-mRNA interaction can be rate-limiting for U1- independent splicing. Genes Dev 1995, 9:2314-2323.
10. Roscigno RF, Garcia-Blanco MA: SR proteins escort U4/6.U5 tri-snRNP to the spliceosome. RNA 1995, 1:692-706.
11. Valcárcel J, Gaur RK, Singh R, Green MR: Interaction of U2AF65 RS region with pre-mRNA of branch point and promotion base pairing with U2 snRNA. Science 1996, 273:1706-1709. Discovery of a novel function of the U2AF65 RS domain: it binds to the pre-mRNA branch site and promotes U2 snRNA-branch site base pairing.
12. Crispino JD, Mermoud JE, Lamond AL, Sharp PA: Cis-acting elements distinct from the 5′ splice site promote U1-independent pre-mRNA splicing. RNA 1996, 2:664-673. Splicing of certain substrates occurs in U1 snRNP-depleted nuclear extract without addition of SR proteins. Cis-acting sequences other than splicing signals are required for U1 snRNP-independent splicing.
13. Tacke R, Manley JL: The human splicing factors ASF/SF2 and SC35 possess different, functionally significant RNA binding specificities. EMBO J 1995, 14:3540-3551.
14. Zuo P, Maniatis T: The splicing factor U2AF35 mediates critical protein-protein interactions in constitutive and enhancerdependent splicing. Genes Dev 1996, 10:1356-1368. This study establishes the essential role of U2AF35 in constitutive and enhancer-dependent splicing and further shows that U2AF35 is required for enhancer-dependent binding of U2AF65 to the 3′ splice site.
15. Tian M, Maniatis T: A splicing enhancer exhibits both constitutive and regulated activities. Genes Dev 1994, 8:1703-1712.
16. Lynch KW, Maniatis T: Synergistic interactions between two distinct elements of a regulated splicing enhancer. Genes Dev 1995, 9:234-293.
17. Lynch KW, Maniatis T: Assembly of specific SR protein complexes on distinct regulatory elements of the Drosophila doublesex splicing enhancer. Genes Dev 1996, 10:2089-2101. A detailed study of protein binding on Drosophila doublesex splicing enhancer. Splicing factors Transformer, Transformer 2 are shown to recruit different SR proteins to the repeat region and the purine-rich element of the doublesex splicing enhancer. The binding of Transformer, Transformer 2 and SR proteins to the RNA is synergistic. The relative positions of these bound splicing factors on the RNA were determined.
18. Heinrichs V, Baker BS: The Drosophila SR protein RBP1 contributes to the regulation of doublesex alternative splicing by recognizing RBP1 RNA target sequences. EMBO J 1995, 14:3987-4000.
19. Staffa A, Cochrane A: Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type I. Mol Cell Biol 1995, 15:4597-4605.
20. Amendt BA, Si Z-H, Stoltzfus CM: Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tal-rev exon 3: evidence for inhibition mediated by cellular factors. Mol Cell Biol 1995, 15:4606-4615.
21. Zheng ZM, He P, Baker CC: Selection of the bovine papillornavirus type 1 nucleotide 3225 3 splice site is regulated through an exonic splicing enhancer and its juxtaposed exonic splicing suppressor. J Virol 1996, 70:4891-4699.
22. Shih SR, Krug RM: Novel exploitation of a nuclear function by influenza virus: the cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells. EMBO J 1996, 15:5415-5427. An exon-splicing enhancer on influenza virus pre-mRNA stimulates viral M2 mRNA splicing. ASF/SF2 was shown to bind the enhancer and to activate M2 splicing in vitro. The amount of M2 mRNA and protein produced in different virus-infected cell lines correlates with the levels of ASF/SF2.
23. Zhang L, Ashiya M, Sherman TG, Grabowski PJ: Essential nucleotides direct neuron-specific splicing of γ2 pre-mRNA. RNA 1996, 2:682-698.
24. Ryan KJ, Cooper TA: Muscle-specific splicing enhancers regulate inclusion of the cardiac troponin T alternative exon in embryonic skeletal muscle. Mol Cell Biol 1996, 16:4014-4023.
25. König H, Moll J, Ponta H, Herrlich P: Transformerns-acting factors regulate the expression of CD44 splice variants. EMBO J 1996, 15:4030-4039.
26. Min H, Chan RC, Black DL: The generally expressed hnRNP F is involved in a neural- specific pre-mRNA splicing event. Genes Dev 1996, 10:2659-2671. See annotation [27*].
27. Min H, Turck CW, Black DL: A new regulatory protein, KSR, mediates exon inclusion through an intronic splicing enhancer. Genes Dev 1997, in press. By using neural-specific inclusion of c-src N1 exon as a working model, these authors have identified and characterized a 75 kDa protein, KSR, required for N1 splicing in vitro. KSR contains KH-type RNA binding motifs and may play an important role in neural-specific splicing.
28. McNally LM, McNally MT: SR protein splicing factors interact with the Rous sarcoma virus negative regulator of splicing element. J Virol 1996, 70:1163-1172.
29. Kanopka A Mühlemann O, Akusjärvi G: SR proteins that are essential for generic pre-mRNA splicing inhibit splicing of a regulated adenovirus pre-mRNA. Nature 1995, 381:535-538. An intronic sequence element is shown to repress splicing of adenovirus IIIa mRNA splicing. SR proteins, specifically ASF/SF2, are found to bind the element and to mediate splicing inhibition, probably by steric hindrance. The position of the element in the pre-mRNA determines whether its effect is either positive or negative.
30. Himmelspach M, Cavaloc Y, Chebli K, Stevenin J, Gattoni R: Titration of serine/arginine (SR) splicing factors during adenoviral infection modulates E1A pre-mRNA alternative splicing. RNA 1996, 2:794-306.
31. Siebel CW, Kanaar R, Rio DC: Regulation of tissue-specific P element pre-mRNA splicing requires the RNA-binding protein PSI. Genes Dev 1994, 8:1713-1725.
32. Siebel CW, Admon A, Rio DC: Soma-specific expression and cloning of PSI, a negative regulator of P element pre-mRNA splicing. Genes Dev 1995, 9:269-233.
33. Adams MD, Tarng RS, Rio DC: The alternative splicing factor PSI regulates P-element third intron splicing in vivo. Genes Dev 1997, 11:129-138. Experiments carried out in Drosophila demonstrate that PSI is a tissue specific splicing inhibitor in vivo. Ectopic expression of PSI in the female germline inhibits P element IVS3 silencing and blocking expression of PSI results in activation of IVS3 splicing in soma.
34. Cáceres JF, Stamm S, Helfman DM, Krainer AR: Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 1994, 265:1706-1709.
35. Wang J, Manley JL: Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways. RNA 1995, 1:335-346.
36. Screaton GR, Cáceres JF, Mayeda A, Bell MV, Plebanski M, Jackson DG, Bell JI, Krainer AR: Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J 1995, 14:4336-4349.
37. Romac JMJ, Keene J: Overexpression of the arginine-rich carboxyl-terminal region of U1 snRNP 70K inhibits both splicing and nucleocytoplasmic transport of mRNA. Genes Dev 1995, 9:1400-1410.
38. Wu JY, Maniatis T: Specific interactions between proteins implicated in splice site selection and regulated alternative splicing. Cell 1993, 75:1061-1070.
39. Kohtz JD, Jamison SF, Will CL, Zuo P, Lührmann R, Garcia-Blanco MA, Manley JL: Protein-protein interactions and 5′-splicesite recognition in mammalian mRNA precursors. Nature 1994, 368:119-124.
40. Diamond RH, Du K, Lee VM, Mohn KL, Haber BA, Tewari DS, Taub R: Novel delayed-early and highly insulin-induced growth response genes: identification of HRS, a potential regulator of alternative pre-mRNA splicing. J Biol Chem 1993, 268:15185-15192.
41. Zahler AM, Neugenbauer KM, Lane WS, Roth MB: Distinct functions of SR proteins in alternative pre-mRNA splicing. Science 1993, 260:219-222.
42. Ring HZ, Lis JT: The SR protein B52/SRp55 is essential for Drosophila development Mol Cell Biol 1994, 14:7499-7506.
43. Peng X, Mount SM: Genetic enhancement of RNA processing defects by a dominant mutation in B52, the Drosophila gene for an SR protein splicing factor. Mol Cell Biol 1995, 15:6273-6232.
44. Wang J, Takagaki Y, Manley JL: Targeted disruption of an essential vertebrate gene: ASF/SF2 is required for cell viability. Genes Dev 1996, 10:2588-2599. Development of a genetic system to disrupt an essential gene in vertebrate cells. These authors used this system to demonstrate that ASF/SF2 is required for cell viability and to define domains at the protein essential for function in vivo.
45. Mermoud J, Cohen PTW, Lamond AL: Regulation of mammalian spliceosome assembly by a protein phosphorylation mechanism. EMBO J 1994, 13:5679-5638.
46. Woppmann A, Will CL, Kornstadt U, Zuo P, Manley JL, Lührmann R: Identification of an snRNP-associated kinase activity that phosphorylates arginine/serine rich domains typical of splicing factors. Nucleic Acids Res 1993, 21:2815-2822.
47. Gui JF, Lane WS, Fu XD: A serine kinase regulates intracellular localization of splicing factors in the cell cycle. Nature 1994, 369:678-682.
48. Colwill K, Pawson T, Andrews B, Prasad J, Manley JL, Bell JC, Duncan PI: The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intracellular distribution. EMBO J 1996, 15:265-275. Clk/Sty kinase is shown to interact with SR proteins in yeast two-hybrid screening. In vitro assays indicate that Clk/Sty phosphorylates the RS domain of ASF/SF2 in a manner very similar to that detected in vivo. Clk/Sty colocalizes with SR proteins in vivo.
49. Rossi F, Labourier E, Forné T, Divita G, Derancourt J, Riou JF, Antoine E, Cathala G, Brunel C, Tazi J: Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I. Nature 1995, 381:80-32.
50. Perutz MF, Staden R, Moens L, De Baere I: Polar zippers. Curr Biol 1993, 3:249-253.
51. Tacke R, Chen Y, Manley JL: Sequence-specific RNA binding by an SR protein requires RS domain phosphorylation: creation of an SRp40-specific splicing enhancer. Proc Natl Acad Sci USA 1997, 94:1146-1153. This study shows that phosphorylation of the RS domain of SRp40 is essential for sequence-specific RNA binding. High-affinity binding sites for SRp40 selected by SELEX function as splicing enhancers in vitro.
52. Xiao SH, Manley JL: Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. Genes Dev 1997, 11:334-344. Phosphorylation of ASF/SF2 enhances an RS domain-mediated interaction with U1 70K protein and with U1 snRNP. Conditions are described in which phosphorylation of ASF/SF2 is found to be necessary for efficient splicing in vitro.
53. Hanes J. Von Der Kammer H, Klaudiny J, Scheit KH: Characterization by cDNA cloning of two new human protein kinases: evidence by sequence comparison of a new family of mammalian protein kinases. J Mol Biol 1994, 244:565-672.